Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Katrina L. Oie"'
Autor:
Katrina L. Oie, John E. Fuchs, Dean T. Martin, Gary E. Pakes, Benjamin Daquioag, Joseph C. Gathe, Vanessa C. Williams, M. Keith Rawlings
Publikováno v:
World Journal of AIDS. :245-251
Objective: The purpose of this study was to investigate whether switching HIV-infected patients stabilized on Trizivir (abacavir 300 mg/lamivudine 150 mg/zidovudine 300 mg) plus lopinavir/ritonavir 400 mg/100mg twice daily to Trizivir alone affects c
Autor:
Anthony J. Sadler, Bryan R.G. Williams, David J. Pickup, Katrina L. Oie, Ian T.D. Petty, Heather E. Lynch, Justin Pollara, Caroline A. Ray
Publikováno v:
Virology. 391(2):177-186
Modified vaccinia virus Ankara (MVA), which is a promising replication-defective vaccine vector, is unusual among the orthopoxviruses in activating NF-kappaB transcription factors in cells of several types. In human embryonic kidney (HEK 293T) cells,
Autor:
David J. Pickup, Katrina L. Oie
Publikováno v:
Virology. 288(1):175-187
NF-kappaB comprises a family of transcription factors that regulate key immune processes. In this study, the effects of orthopoxvirus infection upon the activation of NF-kappaB were examined. During the early phase of infection, cowpox virus can inhi
Publikováno v:
Antiviral Therapy. 13:735-737
In vitro, the reverse transcriptase mutation K65R can simultaneously reduce drug susceptibility, replicative capacity and restrict HIV-1 replication. Here, we assessed the effect of tenofovir discontinuation for a patient receiving antiretroviral the
Autor:
Lisa L. Ross, Katrina L Oie, Stephen Raffanti, Joseph H. Horton, Richard T. D'Aquila, Keith A. Pappa, Anna Marie Geretti, Elizabeth G Rouse, Asghar Kheshti
Publikováno v:
AIDS research and human retroviruses. 27(2)
Detection of drug resistance is critical for determining antiretroviral treatment options. Ultradeep pyrosequencing (UDPS; 454 Life Sciences) is capable of detecting virus variant subpopulations with much greater sensitivity than population sequencin
Autor:
Ricky, Hsu, Ernest R, Lanier, Elizabeth G, Rouse, Katrina L, Oie, Keith A, Pappa, Lisa L, Ross
Publikováno v:
Antiviral therapy. 13(5)
In vitro, the reverse transcriptase mutation K65R can simultaneously reduce drug susceptibility, replicative capacity and restrict HIV-1 replication. Here, we assessed the effect of tenofovir discontinuation for a patient receiving antiretroviral the
Autor:
Merry E. Schrumpf, Stephen F. Porcella, Katrina L. Oie, Brian Stevenson, Sandra J. Raffel, Lori Lubke, Tom G. Schwan, Cecily A. Fitzpatrick
Borrelia hermsii , an agent of tick-borne relapsing fever, was found to contain multiple circular plasmids approximately 30 kb in size. Sequencing of a DNA library constructed from circular plasmid fragments enabled assembly of a composite DNA sequen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bc96680903d681e18f0dd688a7f0155
https://europepmc.org/articles/PMC101665/
https://europepmc.org/articles/PMC101665/
Publikováno v:
Virology. 251(2)
The ADV-G isolate of Aleutian mink disease parvovirus (ADV) replicates permissively in Crandell feline kidney (CRFK) cells but is nonpathogenic for mink, whereas the highly pathogenic ADV-Utah isolate is nonviable in CRFK cells. To assign control of
Autor:
Frederick Costello, Mavis Agbandje-McKenna, Mark E. Huhtanen, David A. Martin, Katrina L. Oie, James B. Wolfinbarger, Stanley F. Hayes, Marshall E. Bloom
Publikováno v:
Journal of virology. 71(1)
The capsid proteins of the ADV-G isolate of Aleutian mink disease parvovirus (ADV) were expressed in 10 nonoverlapping segments as fusions with maltose-binding protein in pMAL-C2 (pVP1, pVP2a through pVP2i). The constructs were designed to capture th
Autor:
R Hao, Felipe García, F Felizarta, Lisa L. Ross, Catherine B. Small, B Stancil, Katrina L Oie, Keith A. Pappa, Princy Kumar, L Sloan, Belinda Ha, H Edelstein, Gregory D Huhn, Edwin DeJesus
Publikováno v:
Journal of the International AIDS Society
The objective of this study was to evaluate the efficacy, tolerability, and safety of fosamprenavir/ritonavir (FPV/r) versus efavirenz (EFV), both in combination with abacavir/lamivudine (ABC/3TC), in a population that is often underrepresented in U.